Literature DB >> 7675015

MR imaging of the basal ganglia in chronic liver disease: correlation of T1-weighted and magnetisation transfer contrast measurements with liver dysfunction and neuropsychiatric status.

S D Taylor-Robinson1, A Oatridge, J V Hajnal, A K Burroughs, N McIntyre, N M deSouza.   

Abstract

Conventional T1-weighted spin echo (T1WSE) and T1-weighted magnetization transfer (MT) images were obtained in 26 patients with biopsy-proven cirrhosis (nine Child's grade A, 10 Child's grade B and seven Child's grade C). Four subjects showed no evidence of neuropsychiatric impairment on clinical, psychometric and electrophysiological testing, seven showed evidence of subclinical hepatic encephalopathy and 15 were classified as having overt hepatic encephalopathy. Signal intensities of basal ganglia nuclei (head of caudate, putamen, globus pallidus and thalamus) and adjacent brain parenchyma were measured and contrast calculated. On T1WSE imaging, contrast measurements of the globus pallidus were significantly greater in patients with neuropsychiatric dysfunction than in those who were unimpaired (p < 0.05). This was not observed in the other basal ganglia nuclei. Patients with subclinical and overt hepatic encephalopathy could not be distinguished on the basis of contrast measurements of the globus pallidus or of any other nucleus. T1WSE contrast measurements of the globus pallidus were increased with elevations in blood ammonia levels (p < 0.05) and with the severity of liver dysfunction, when graded according to the Pugh's score (p < 0.05) Those patients with the worst liver injury (Child's grade C) had significantly greater T1WSE pallidal contrast measurements (p < 0.05) than those patients with minimal liver injury (Child's grade A). The patients with intermediate liver damage (Child's grade B) could not be distinguished from the other two groups. While MT imaging highlighted the basal ganglia and showed a correlation between globus pallidus contrast and blood ammonia levels (p < 0.05), no other relationship between MT contrast measurements and either the degree of hepatic encephalopathy or the severity of liver dysfunction was found.

Entities:  

Mesh:

Year:  1995        PMID: 7675015     DOI: 10.1007/bf01991864

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  26 in total

1.  Hyperintensity in the globus pallidus on T1-weighted and inversion-recovery MRI: a possible marker of advanced liver disease.

Authors:  A Pujol; F Graus; J Peri; J M Mercader; A Rimola
Journal:  Neurology       Date:  1991-09       Impact factor: 9.910

2.  Hyperintense basal ganglia on T1-weighted MR images in patients receiving parenteral nutrition.

Authors:  S A Mirowitz; T J Westrich; J D Hirsch
Journal:  Radiology       Date:  1991-10       Impact factor: 11.105

3.  Design and implementation of magnetization transfer pulse sequences for clinical use.

Authors:  J V Hajnal; C J Baudouin; A Oatridge; I R Young; G M Bydder
Journal:  J Comput Assist Tomogr       Date:  1992 Jan-Feb       Impact factor: 1.826

4.  Volatile fatty acids in the breath of patients with cirrhosis of the liver.

Authors:  S Chen; V Mahadevan; L Zieve
Journal:  J Lab Clin Med       Date:  1970-04

5.  The Revised Kendrick Battery: clinical studies.

Authors:  D C Kendrick; A J Gibson; I C Moyes
Journal:  Br J Soc Clin Psychol       Date:  1979-09

6.  Increased manganese concentrations in pallidum of cirrhotic patients.

Authors:  G Pomier-Layrargues; L Spahr; R F Butterworth
Journal:  Lancet       Date:  1995-03-18       Impact factor: 79.321

7.  Chronic acquired hepatic failure: MR imaging of the brain at 1.5 T.

Authors:  J A Brunberg; E Kanal; W Hirsch; D H Van Thiel
Journal:  AJNR Am J Neuroradiol       Date:  1991 Sep-Oct       Impact factor: 3.825

8.  A quantitative evaluation of magnetic resonance image signal changes of the brain in chronic hepatic encephalopathy.

Authors:  N S Norton; J R McConnell; R K Zetterman; J F Rodriguez-Sierra
Journal:  J Hepatol       Date:  1994-11       Impact factor: 25.083

9.  Regional variations in cerebral proton spectroscopy in patients with chronic hepatic encephalopathy.

Authors:  S D Taylor-Robinson; J Sargentoni; C D Marcus; M Y Morgan; D J Bryant
Journal:  Metab Brain Dis       Date:  1994-12       Impact factor: 3.584

Review 10.  Ammonia: key factor in the pathogenesis of hepatic encephalopathy.

Authors:  R F Butterworth; J F Giguère; J Michaud; J Lavoie; G P Layrargues
Journal:  Neurochem Pathol       Date:  1987 Feb-Apr
View more
  26 in total

Review 1.  Cerebral magnetic resonance imaging in patients with chronic liver disease.

Authors:  M Y Morgan
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 2.  Role of manganese in the pathogenesis of portal-systemic encephalopathy.

Authors:  G P Layrargues; C Rose; L Spahr; J Zayed; L Normandin; R F Butterworth
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

3.  Two patterns of cerebral metabolite abnormalities are detected on proton magnetic resonance spectroscopy in HIV-infected subjects commencing antiretroviral therapy.

Authors:  Alan Winston; Chris Duncombe; Patrick C K Li; John M Gill; Stephen J Kerr; Rebekah L Puls; Simon D Taylor-Robinson; Sean Emery; David A Cooper
Journal:  Neuroradiology       Date:  2012-07-07       Impact factor: 2.804

4.  Quantitative magnetic resonance imaging in patients with cirrhosis: a cross-sectional study.

Authors:  Vijay P B Grover; Mary M E Crossey; Julie A Fitzpatrick; Brian K Saxby; Roberta Shaw; Adam D Waldman; Marsha Y Morgan; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2015-08-08       Impact factor: 3.584

Review 5.  Proton magnetic resonance spectroscopy in portal-systemic encephalopathy.

Authors:  H Köstler
Journal:  Metab Brain Dis       Date:  1998-12       Impact factor: 3.584

Review 6.  Acquired hepatocerebral degeneration.

Authors:  Joseph Ferrara; Joseph Jankovic
Journal:  J Neurol       Date:  2009-02-17       Impact factor: 4.849

Review 7.  The role of magnetic resonance imaging and spectroscopy in hepatic encephalopathy.

Authors:  Mark J W McPhail; Simon D Taylor-Robinson
Journal:  Metab Brain Dis       Date:  2010-03-11       Impact factor: 3.584

Review 8.  Multimodal MR imaging in hepatic encephalopathy: state of the art.

Authors:  Xiao Dong Zhang; Long Jiang Zhang
Journal:  Metab Brain Dis       Date:  2018-01-26       Impact factor: 3.584

9.  In vivo imaging of cerebral "peripheral benzodiazepine binding sites" in patients with hepatic encephalopathy.

Authors:  A Cagnin; S D Taylor-Robinson; D M Forton; R B Banati
Journal:  Gut       Date:  2005-10-06       Impact factor: 23.059

Review 10.  Movement dysfunction and hepatic encephalopathy.

Authors:  G P Layrargues
Journal:  Metab Brain Dis       Date:  2001-06       Impact factor: 3.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.